Robert F. Kennedy Jr.'s newly appointed vaccine advisory panel, comprised largely of vaccine skeptics, will review established childhood immunization schedules. This includes examining vaccines approved seven or more years ago, such as the hepatitis B vaccine for newborns, prompting concerns from public health experts about potential bias and flawed processes. The panel's first meeting saw the postponement of recommendations on RSV vaccines and the inclusion of a presentation on thimerosal, a mercury-based preservative largely removed from vaccines. Critics, including Senator Bill Cassidy, have raised concerns about the panel's composition, experience, and potential conflicts of interest.

Prepared by Olivia Bennett and reviewed by editorial team.